Skip to search.
 TSX Down 0.08% TSX Ventures Up 0.73%

More On TTH.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Transition Therapeutics Inc (TTH.TO)

-Toronto
1.34 Down 0.02(1.47%) Feb 5, 3:50PM EST
Prev Close:1.36
Open:1.39
Bid:1.25
Ask:1.50
1y Target Est:N/A
Beta:2.50425
Next Earnings Date: 9-Feb-16TTH.TO Earnings announcement
Day's Range:1.33 - 1.39
52wk Range:1.18 - 11.50
Volume:1,600
Avg Vol (3m):5,263
Market Cap:52.10M
P/E (ttm):N/A
EPS (ttm):-1.07
Div & Yield:0.06 (0.20%)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :N/A
Quarterly EPS Est (Jun-15) :N/A
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications primarily in Canada. The company's lead central nervous system drug candidate is ELND005, which has completed a Phas... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback